Recombinant Human Angiopoietin-like 4 Biotin Protein, CF
R&D Systems, part of Bio-Techne | Catalog # BT4487
Key Product Details
Source
NS0
Accession #
Structure / Form
Oligomer. Biotinylated via sugars
Conjugate
Biotin
Applications
Bioactivity
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human Angiopoietin-like Protein 4/ANGPTL4 protein
Gly26-Ser406 (Lys163Ala, Arg164Ala), with a C-terminal 6-His tag
Gly26-Ser406 (Lys163Ala, Arg164Ala), with a C-terminal 6-His tag
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Gly26
Predicted Molecular Mass
44 kDa (unlabeled)
Activity
Measured by its ability to promote the expansion of E16 rat liver mononuclear cells in vitro, in the presence of Recombinant Mouse SCF/c-kit Ligand (Catalog # 455-MC), Recombinant Mouse Thrombopoietin/Tpo (Catalog # 488-TO), and Recombinant Mouse Flt-3 Ligand (Catalog # 427-FL).
The ED50 for this effect is 100-600 ng/mL in the presence of a cross-linking antibody, His Tag MAb, Mouse Anti-polyHistidine Monoclonal Antibody (Catalog # MAB050).
The ED50 for this effect is 100-600 ng/mL in the presence of a cross-linking antibody, His Tag MAb, Mouse Anti-polyHistidine Monoclonal Antibody (Catalog # MAB050).
Reviewed Applications
Read 1 review rated 5 using BT4487 in the following applications:
Scientific Data Images for Recombinant Human Angiopoietin-like 4 Biotin Protein, CF
Recombinant Human Angiopoietin-like 4 Biotin Protein Bioactivity
Both Biotinylated Recombinant Human Angiopoietin-like Protein 4/ANGPTL4 (Catalog # BT4487) and unlabeled Recombinant Human Angiopoietin-like Protein 4/ANGPTL4 (Catalog # 4487-AN) promotes the expansion of E16-E18 rat liver mononuclear cellsin vitro, in the presence of Recombinant Mouse SCF/c-kit Ligand (Catalog # 455-MC), Recombinant Mouse Thrombopoietin/Tpo (Catalog # 488-TO), and Recombinant Mouse Flt-3 Ligand (Catalog # 427-FL). The ED50 for this effect is 100-600 ng/mL in the presence of a cross-linking antibody, His Tag MAb (Catalog # MAB050). The similarity in activity highlights that the biotinylated protein is fully functional.Formulation, Preparation and Storage
BT4487
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, NaCl and CHAPS. |
Reconstitution |
Reconstitute at 500 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Angiopoietin-like Protein 4/ANGPTL4
References
- Zhu, P. et al. (2012) Biosci. Rep. 32:211.
- Ge, H. et al. (2004) J. Biol. Chem. 279:2038.
- Sukonina, V. et al. (2006) Proc. Natl. Acad. Sci. USA 103:17450.
- Mandard, S. et al. (2006) J. Biol. Chem. 281:934.
- Xu, A. et al. (2005) Proc. Natl. Acad. Sci. USA 102:6086.
- Kersten, S. et al. (2000) J. Biol. Chem. 275:28488.
- Cazes, A. et al. (2006) Circ. Res. 99:1207.
- Le Jan, S. et al. (2003) Am. J. Pathol. 162:1521.
- Goh, Y.Y. et al. (2010) Am. J. Pathol. 177:2791.
- Goh, Y.Y. et al. (2010) J. Biol. Chem. 285:32999.
- Blank, U. et al. (2012) Eur. J. Haematol. 89:198.
- Hou, M. et al. (2014) PLoS ONE 9:e85808.
- Clement, L.C. et al. (2011) Nat. Med. 17:117.
Alternate Names
Angiopoietin like Protein 4, ANGPTL4, FIAF, HFARP, PGAR
Gene Symbol
ANGPTL4
UniProt
Additional Angiopoietin-like Protein 4/ANGPTL4 Products
- All Products for Angiopoietin-like Protein 4/ANGPTL4
- Angiopoietin-like Protein 4/ANGPTL4 cDNA Clones
- Angiopoietin-like Protein 4/ANGPTL4 ELISA Kits
- Angiopoietin-like Protein 4/ANGPTL4 Lysates
- Angiopoietin-like Protein 4/ANGPTL4 Primary Antibodies
- Angiopoietin-like Protein 4/ANGPTL4 Proteins and Enzymes
- Angiopoietin-like Protein 4/ANGPTL4 Simple Plex
Product Documents for Recombinant Human Angiopoietin-like 4 Biotin Protein, CF
Product Specific Notices for Recombinant Human Angiopoietin-like 4 Biotin Protein, CF
For research use only
Loading...
Loading...
Loading...
Loading...